just discovered insulin analogs for...

just discovered insulin analogs for the treatment of diabetes perform the operations indicated ined over the past decade can simplify insulin dosing regimens and improve flexibility for patients. upright diabetes control often requires the use of insulin, which may save beta-cell function and improve lipid metabolism and survival after myocardial infarction. DeWitt and Hirsch searched MEDLINE for all English-language articles involving insulin use in adult patients with prototype 1 and type 2 diabetes. The researchers build that many trials were designed poorly and were sponsored by means of pharmaceutical companies, and concluded that skilled hand clinical practice is far ahead of research.

In reviewing the originals of insulin, the authors identify rapid-acting insulin (such as insulin lispro and insulin aspart), short-acting regular insulin, intermediate-acting neutral protamine Hagedorn (NPH) insulin and Lente insulin, and long-acting insulin (such as Ultralente insulin and insulin glargine). Hypoglycemia is the major adverse meaning of insulin therapy, with the majority of episodes occurring nocturnally. Intensive therapy with insulin increases a patient's risk of stern hypoglycemia. Another adverse effect of insulin therapy is weight gain, which can be decreased with bedtime administration of insulin. Retinopathy can worsen with rapid improvement in glycemic control

Multiple injections with prandial insulin (used before meals) gives patients greater lifestyle flexiblility. NPH and regular insulin provide basal and prandial imports For this reason, preventing midmorning hypoglycemia and ensuring a timely luncheon are important aspects of glycemic management. A short-acting or rapid-acting insulin appendix should be used to correct hyperglycemia. In patients with impressed sign 2 diabetes, the authors attract favor to 1 U of supplemental insulin for each 30 mg by dL (1.7 mmol per L) above the target grape-sugar level.

Insulin supplementation between meals is more complicated because of the potential for "insulin stacking," or accumulation of insulins. Physicians should consider starting insulin therapy in patients whose hemoglobin A1c approaches 8 percent despite optimal therapy. Patients frequently require dosages of greater than 100 U by means of day to achieve optimal therapy. The use of metformin with insulin may be the best combination regimen, because it typically springs in less weight gain and fewer hypoglycemic episodes. The combination of sulfonylureas and insulin becomes ineffective in patients whose A1c on a level approaches 10 percent. NPH and glargine can be adjusted easily based upon fasting nocturnal glucose levels. Glargine may arise in fewer nocturnal hypoglycemic episodes and les weight gain, still it costs twice as a great deal of as NPH. If nocturnal hypoglycemia cannot be controll and glargine cannot be used, the patient can use prandial lispro in combination with sulfonylureas. In patients having difficulty achieving daytime hinder premixed insulin regimens at the same insulin dosage can be helpful. Lunchtime prandial insulin should be added, and the morning insulin dose should be decreased accordingly.

The authors gather that limited data suggest that using insulin may be cost-effective according to reducing the complications of diabetes. They add that an efficient diabetes care team is frequently lacking, especially in the primary care setting.

DeWitt DE Hirsch IB. Outpatient insulin therapy in stamp 1 and type 2 diabetes mellitus. JAMA May 7 2003;289: 2254-64

COPYRIGHT 2004 American Academy of Family Physicians

COPYRIGHT 2004 Gale Group